Email address
[email protected]Contact number
(212) 558 3370Share profile
Band 2
Provided by Matthew Friestedt
Executive Compensation; Mergers & Acquisitions; Private Equity
Matt Friestedt leads the Firm’s executive compensation M&A practice. He is experienced in handling all matters involving the compensation of senior executives, including employment, change in control, equity compensation and severance arrangements. He has worked on over $2 trillion of M&A transactions and written extensively on executive compensation practices and the Section 280G “golden parachute” tax rules. He also regularly advises on governance issues.
Recent representations include: Amazon.com’s $14 billion acquisition of Whole Foods; AT&T’s $109 billion acquisition of Time Warner and spin-off of WarnerMedia; Bayer’s $66 billion acquisition of Monsanto; Biohaven’s $12 billion sale to Pfizer; Concho’s $14 billion sale to ConocoPhillips and $10 billion acquisition of RSP Permian; Credit Suisse’s $3 billion sale to UBS; Enbridge’s $43 billion acquisition of Spectra; Fiserv’s $22 billion acquisition of First Data; GGP’s $28 billion sale to Brookfield; Harris’ $35 billion merger of equals with L3; Kite Pharma’s $12 billion sale to Gilead Sciences; Kraft’s $55 billion merger with Heinz; PRA Health Sciences $12 billion sale to ICON; Seagen’s $43 billion sale to Pfizer; Teva’s $40 billion acquisition of Allergan Generics; Triton’s $13 billion sale to Brookfield Infrastructure; and UnitedHealth’s $14 billion acquisition of Change Healthcare.
ABA; NYSBA.
New York University School of Law (LLM, 1997); Vanderbilt University School of Law (JD, 1996); University of the Pacific (BS, 1993).
Provided by Chambers
Matthew Friestedt is well regarded in the market for his notable experience managing various compensation and executive matters stemming from corporate transactions.
Provided by Chambers
"Matthew is wicked-sharp and phenomenal."
"Matthew is wicked-sharp and phenomenal."
